Other languages Hester Biosciences Limited

Equities

HESTERBIO

INE782E01017

Delayed Bombay S.E. Other stock markets 04:23:02 2024-05-02 am EDT			5-day change	1st Jan Change
1,699 ^INR	+3.21%		+2.82%	+16.45%

Feb. 29	Hester Biosciences Names COO	MT
Feb. 29	Hester Biosciences Limited Announces Executive Changes	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hester Biosciences Names COO	Feb. 29
Hester Biosciences Limited Announces Executive Changes	Feb. 29
Hester Biosciences Sees Sharp Decline in Fiscal Q3 Consolidated Profit	Feb. 02
Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 02
Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 07
Hester Biosciences Limited Recommends Dividend for the Financial Year 2022-23, Dividend Payment Date on or After Monday, 25 September 2023	23-08-23
Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-08
Hester Biosciences Limited Announces Board Appointments	23-06-27
Hester Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-17
Hester Biosciences Limited Recommends Dividend for the Financial Year 2022-23	23-05-17
Hester Biosciences Limited Announces Resignation of Directors	23-03-27
Hester Biosciences Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	23-01-31
Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-31
Hester Biosciences Limited completed the acquisition of 22.5% stake in Thrishool Exim Limited.	22-12-30
Hester Signs Agreement Towards Receiving Indigenously Developed Technology from Indian Council of Agricultural Research	22-12-28
Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-04
Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-10
Hester Biosciences Limited Efforts to Combat the Current Outbreak of Lumpy Skin Disease in Gujarat and Certain Other Parts of India	22-07-20
Hester Biosciences Limited Recommends Dividend for the Financial Year 2021-22	22-05-20
Hester Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Hester Biosciences Limited

Equities

HESTERBIO

INE782E01017

Other languages

Filters